A developmental safety study in rats using DHA- and ARA-rich single-cell oils

Area of Science:

• Nutritional Science
• Developmental Toxicology
• Maternal-Fetal Medicine

Background:

• Long-chain omega-3 and omega-6 fatty acids, DHA and ARA, are crucial for fetal development.
• Maternal nutrient stores can be depleted during pregnancy and lactation.
• Dietary supplementation may be necessary to maintain maternal reserves and support infant development.

Purpose of the Study:

• To evaluate the potential teratogenic activity of concentrated DHA (DHASCO) and ARA (ARASCO) oils.
• To ensure the safety of these oils for maternal and fetal use during pregnancy.
• To establish a safety margin for DHA and ARA oil supplementation.

Main Methods:

• Pregnant rats were administered DHASCO and ARASCO oils via oral gavage during organogenesis.
• Doses tested were up to 1250 mg/kg/day for DHASCO and 2500 mg/kg/day for ARASCO.
• Maternal reproductive outcomes and fetal development (external, soft tissue, skeletal) were examined on day 20 of gestation.

Main Results:

• No overt maternal toxicity was observed with either oil.
• No significant changes in reproductive parameters (implantation, resorptions, live births, sex ratio) were noted.
• No fetal malformations were induced; renal variations were non-dose-dependent and not toxicologically significant.

Conclusions:

• DHASCO and ARASCO oils are not teratogenic in rats at doses up to 100 times expected human exposure levels.
• These findings support the safe use of concentrated DHA and ARA oils during pregnancy.
• Supplementation with DHA and ARA can help maintain maternal nutrient status and support optimal fetal development.